IRIS
CAVALLONI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 256
EU - Europa 186
AS - Asia 66
AF - Africa 1
Totale 509
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 242
IE - Irlanda 113
CN - Cina 64
DE - Germania 24
FI - Finlandia 18
IT - Italia 17
CA - Canada 14
GB - Regno Unito 4
SE - Svezia 4
BG - Bulgaria 2
FR - Francia 2
NL - Olanda 2
IN - India 1
MU - Mauritius 1
QA - Qatar 1
Totale 509
Salva come PNG Salva come JPEG
Città #
Dublin 113
Chandler 66
Beijing 35
Ashburn 26
Helsinki 18
Lawrence 14
New York 14
Princeton 14
Toronto 13
Medford 11
Wilmington 9
Shanghai 8
Nanjing 6
Washington 5
Gallarate 4
Norwalk 4
Falls Church 3
Fano 3
Nanchang 3
Antony 2
Dronten 2
Falkenstein 2
Florence 2
Hangzhou 2
Hebei 2
Jacksonville 2
Jiaxing 2
Los Angeles 2
Milan 2
Seattle 2
Sofia 2
Tianjin 2
Woodbridge 2
Berlin 1
Changsha 1
Chesterfield 1
Doha 1
Jinan 1
Leawood 1
Monmouth Junction 1
Ningbo 1
Pavia 1
Pune 1
San Francisco 1
Settimo Torinese 1
Shenyang 1
Totale 410
Salva come PNG Salva come JPEG
Nome #
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms 64
Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin 51
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project. 46
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria. 41
Diagnosis and management of prefibrotic myelofibrosis. 40
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia. 39
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. 33
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms 33
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis. 32
Pregnancy outcome and management of 25 pregnancies in women with polycythemia vera. 31
Facing erythrocytosis: Results of an international physician survey. 31
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients. 30
Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib 28
Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients. 27
Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin's B lymphoma: a single center prospective clinico-pathological study 2
Totale 528
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202075 8 11 0 0 0 0 2 13 8 19 10 4
2020/202119 4 1 2 3 0 0 1 2 6 0 0 0
2021/202270 0 0 12 2 3 3 1 3 3 1 11 31
2022/2023238 26 12 8 9 15 16 0 14 123 4 10 1
2023/2024118 18 24 8 7 8 37 2 9 3 2 0 0
Totale 528